The Society for Vascular Surgery (SVS), the leading not-for-profit, professional medical society on establishing causes and treatments for vascular disease, today announced its officers for 2021-2022. Several officers shifted roles and Dr. Joseph L. Mills was elected vice president at the SVS annual business meeting held virtually on June 16, 2021.
Hyperlipidemia is an umbrella term that refers to any of several acquired or genetic disorders that result in a high level of lipids (fats, cholesterol and triglycerides) circulating in the blood. These lipids can enter the walls of arteries and increase your risk of developing atherosclerosis (hardening of the arteries), which can lead to stroke, heart attack and the need to amputate. The risk of atherosclerosis is higher if you smoke, or if you have or develop diabetes, high blood pressure and kidney failure.
This training program, the Harvard-Longwood Research Training in Vascular Surgery program, currently in its 26th year is designed to provide two years of intense basic and outcomes research training in vascular surgery for academic clinicians.
Trainees carry out their research projects under the guidance of a faculty advisor, selected from 20 renowned vascular researchers based at Harvard Medical School hospitals: the Beth Israel Deaconess Medical Center, Brigham and Women's, Children's Hospital, the Joslin Diabetes Institute, The Massachusetts Institute of Technology, and the Harvard School of Engineering and Applied Sciences. Laboratory training is supplemented by graduate level training at Harvard Medical School and Harvard's Faculty of Arts and Sciences, with course selection complementing laboratory endeavors.
Applicants should be US citizens or permanent residents who are resident physicians. Most will have completed either two or three years of surgical residency or five years of clinical training (i.e. are board eligible). Only those applicants with career goals in academic surgery, with a keen interest in basic research in vascular surgery, will be compatible. Candidates pursuing a fellowship during a program of clinical training must provide evidence that they will be accepted back into that program upon completion of their research training.
Selection is based on merit only, without bias to gender, sexual orientation, race, color, or ethnic origin.
NIH Stipend, benefits, and academic appointment at Harvard Medical School as a Research Fellow.
CVISE is the first innovation center in the country to be funded by a T32 training grant from the National Heart, Lung, and Blood Institute of the NIH. The CVISE fellowship accepts four trainees per year: two surgical residents and two engineering students. Trainees in this two-year fellowship program synergize across disciplines to develop, test and patent novel technologies.
This fellowship will help you to:
This fellowship is open to:
If you are eligible and interested in the position, please visit the CVISE website for more information. Applications are due March 30, 2024.
Psychologists place great emphasis on the object permanence milestone, but object impermanence is the more brutal lesson. My experience is now familiar and commonplace. Hundreds of thousands of Americans have lost a parent during the pandemic. Our usual methods of closure have been stripped from us. People are dying in isolation, and the ones they leave behind must often grieve alone. Our failure to control the pandemic has had profound psychological consequences beyond the endless death toll. Our country has risen to similar challenges before, and I believe it will again if we learn from the mistakes we made this year. To accomplish this, we must create a complete account of the costs we have endured.
As the election nears, most of you identify as Democrat or Republican. Without abandoning your core beliefs, I would ask you to consider another affiliation—that of a scientist. Scientists can be progressive or conservative. Their one shared political principle is anti-authoritarianism. Tyrants have taken many roles: dictator, pope and king. Regardless of the form, eventually he (it is usually he) needs to tear down the truth. And it is science that stands in the way.
A few years ago, in his presidential address to the Midwestern Vascular Surgical Society, Mark Mattos, MD, spoke eloquently about the need to “protect our specialty.” A large part of this, he argued, is protecting our patients; no other specialty in medicine can provide the type of comprehensive vascular care that we offer. The daily reality we all face is the potential for declining Medicare reimbursement for our services.
While the COVID-19 pandemic and its effects dominated 2020–21 fiscal year—including the cancellation of the live 2020 Vascular Annual Meeting (VAM)—it did not deter progress on many important initiatives. “When covid hit, it intensified our focus on what was truly important: our members, their patients and the SVS as their Society,” said Executive Director Kenneth M. Slaw, PhD. “That focus was sustained the past 15 months and it has led to innovation and an unprecedented volume of member value programs.” He outlined important highlights from the fiscal year that ended March 31—just more than a year after the pandemic was declared—and the vital initiatives that continue to move forward.